Kempf RA - Search Results

1

Human monoclonal antibodies directed against melanoma tumor-associated antigens.

Kan-Mitchell J, Imam A, Kempf RA, Taylor CR, Mitchell MS. Kan-Mitchell J, et al. Among authors: kempf ra. Cancer Res. 1986 May;46(5):2490-6. Cancer Res. 1986. PMID: 3697990

2

Active specific immunotherapy for melanoma: phase I trial of allogeneic lysates and a novel adjuvant.

Mitchell MS, Kan-Mitchell J, Kempf RA, Harel W, Shau HY, Lind S. Mitchell MS, et al. Among authors: kempf ra. Cancer Res. 1988 Oct 15;48(20):5883-93. Cancer Res. 1988. PMID: 3262416

3

Human monoclonal antibodies that distinguish cutaneous malignant melanomas from benign nevi in fixed tissue sections.

Imam A, Mitchell MS, Modlin RL, Taylor CR, Kempf RA, Kan-Mitchell J. Imam A, et al. Among authors: kempf ra. J Invest Dermatol. 1986 Feb;86(2):145-8. doi: 10.1111/1523-1747.ep12284184. J Invest Dermatol. 1986. PMID: 3528308 Free article.

4

Correlation between cytotoxic and suppressor activities of human pulmonary alveolar macrophages.

Hengst JC, Kan-Mitchell J, Kempf RA, Strumpf IJ, Sharma OP, Kortes VL, Mitchell MS. Hengst JC, et al. Among authors: kempf ra. Cancer Res. 1985 Jan;45(1):459-63. Cancer Res. 1985. PMID: 3871173

5

Cytotoxic activity of human pulmonary alveolar macrophages.

Kan-Mitchell J, Hengst JC, Kempf RA, Rothbart RK, Simons SM, Brooker AS, Kortes VL, Mitchell MS. Kan-Mitchell J, et al. Among authors: kempf ra. Cancer Res. 1985 Jan;45(1):453-8. Cancer Res. 1985. PMID: 3965151

6

Kaposi's sarcoma and autoimmune thrombocytopenia.

Modlin RL, Kempf RA, Mitchell MS, Taylor CR, Davis CR, Rea TH. Modlin RL, et al. Among authors: kempf ra. Cancer Invest. 1984;2(2):97-101. doi: 10.3109/07357908409020292. Cancer Invest. 1984. PMID: 6428708

7

Active-specific immunotherapy for melanoma.

Mitchell MS, Harel W, Kempf RA, Hu E, Kan-Mitchell J, Boswell WD, Dean G, Stevenson L. Mitchell MS, et al. Among authors: kempf ra. J Clin Oncol. 1990 May;8(5):856-69. doi: 10.1200/JCO.1990.8.5.856. J Clin Oncol. 1990. PMID: 2139701

8

Phase I study of recombinant beta-interferon given by four-hour infusion.

Grunberg SM, Kempf RA, Venturi CL, Mitchell MS. Grunberg SM, et al. Among authors: kempf ra. Cancer Res. 1987 Feb 15;47(4):1174-8. Cancer Res. 1987. PMID: 3802098

9

Effects of chemotherapeutic agents on the immune response. I.

Kempf RA, Mitchell MS. Kempf RA, et al. Cancer Invest. 1984;2(6):459-66. doi: 10.3109/07357908409048519. Cancer Invest. 1984. PMID: 6509357 No abstract available.

10

Effects of chemotherapeutic agents on the immune response. II.

Kempf RA, Mitchell MS. Kempf RA, et al. Cancer Invest. 1985;3(1):23-33. doi: 10.3109/07357908509040605. Cancer Invest. 1985. PMID: 2578859 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

45 results

Search Page

Filters